Literature DB >> 7156301

Differentiating anxiety and depression in anxiety disorders: use of rating scales.

R S Lipman.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7156301

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  15 in total

1.  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

2.  Correlates of depressive and anxiety symptoms among the caregivers of leukemic children.

Authors:  Dilek Demirtepe-Saygılı; Ozlem Bozo
Journal:  J Clin Psychol Med Settings       Date:  2011-03

Review 3.  An examination of the tripartite model of anxiety and depression and its application to youth.

Authors:  J Laurent; R Ettelson
Journal:  Clin Child Fam Psychol Rev       Date:  2001-09

4.  Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.

Authors:  Shaun M Eack; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Summer A F McKnight; Srihari S Bangalore; Michael F Pogue-Geile; Matcheri S Keshavan; Jack R Cornelius
Journal:  Schizophr Res       Date:  2014-12-12       Impact factor: 4.939

5.  Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination.

Authors:  Jose Rodríguez-Andreu; Rosario Ibáñez-Bosch; Amparo Portero-Vázquez; Xavier Masramon; Javier Rejas; Rafael Gálvez
Journal:  BMC Musculoskelet Disord       Date:  2009-12-21       Impact factor: 2.362

6.  Psychometric evaluation of a visual analog scale for the assessment of anxiety.

Authors:  Valerie S L Williams; Robert J Morlock; Douglas Feltner
Journal:  Health Qual Life Outcomes       Date:  2010-06-08       Impact factor: 3.186

7.  Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients.

Authors:  Antonietta Fava; Massimiliano Plastino; Dario Cristiano; Antonio Spanò; Stefano Cristofaro; Carlo Opipari; Antonio Chillà; Fatima Casalinuovo; Carmen Colica; Matteo De Bartolo; Domenico Pirritano; Domenico Bosco
Journal:  Metab Brain Dis       Date:  2013-07-28       Impact factor: 3.584

Review 8.  Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis.

Authors:  Yvonne B Suijkerbuijk; Frederieke G Schaafsma; Joost C van Mechelen; Anneli Ojajärvi; Marc Corbière; Johannes R Anema
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

9.  A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease.

Authors:  Janet Hardy; Clare Randall; Eve Pinkerton; Christopher Flatley; Kristen Gibbons; Simon Allan
Journal:  Support Care Cancer       Date:  2016-02-18       Impact factor: 3.603

10.  Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Karla J Alaka; William Noble; Angel Montejo; Héctor Dueñas; Autar Munshi; Jeffrey R Strawn; Alan Lenox-Smith; Jonna Ahl; Leszek Bidzan; Brita Dorn; Susan Ball
Journal:  Int J Geriatr Psychiatry       Date:  2014-02-20       Impact factor: 3.485
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.